|
|
|
Volumn 25, Issue 3 SUPPL. 8, 1998, Pages 24-27
|
|
The integration of newer agents into neoadjuvant therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOCETAXEL;
CANCER ADJUVANT THERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG EFFICACY;
HUMAN;
LUNG NON SMALL CELL CANCER;
METASTASIS;
METASTASIS POTENTIAL;
PRIORITY JOURNAL;
REVIEW;
RISK ASSESSMENT;
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
HUMANS;
LUNG NEOPLASMS;
PROGNOSIS;
SURVIVAL ANALYSIS;
|
|
EID: 0031823202
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (20)
|
|
References (18)
|
